A single-source nosocomial outbreak of Aspergillus flavus uncovered by genotyping

A Gewecke1, R Krøger Hare1, C Salgård2

  • 1Mycology Unit, Department for Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.

Microbiology Spectrum
|June 18, 2024
PubMed

Insights

Microsatellite genotyping identified a specific Aspergillus flavus clone causing a hospital outbreak. This molecular tool helped pinpoint the internal source, enabling targeted environmental cleaning and protecting vulnerable patients.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Hospital-acquired Aspergillus flavus infections pose a significant threat to immunocompromised patients.
  • An increase in A. flavus infections was observed during construction work (2017-2019) in pediatric patients, many on amphotericin B prophylaxis.

Purpose of the Study:

  • To investigate and characterize a potential outbreak of Aspergillus flavus infections using molecular methods.
  • To identify the source and transmission dynamics of A. flavus within a hospital setting.

Main Methods:

  • Microsatellite genotyping was employed to analyze 153 clinical and environmental A. flavus isolates.
  • Cluster analysis was performed using Minimum Spanning Tree (MST) and Discriminant Analysis of Principal Components (DAPC).
  • Environmental air sampling was conducted in the affected ward.

Main Results:

  • DAPC and MST analyses revealed a distinct cluster of A. flavus isolates, including outbreak cases and environmental samples.
  • The outbreak was traced to an internal hospital source, with high A. flavus prevalence found in technical risers.
  • Sealing the identified environmental sources led to negative follow-up air samples.

Conclusions:

  • Microsatellite genotyping is a valuable tool for documenting isogenic hospital outbreaks and identifying internal sources.
  • Rapid source identification and control measures are crucial for managing A. flavus outbreaks.
  • Protecting vulnerable patients and early inclusion of genotyping in investigations are recommended.